What to know about RSV vaccine candidates and monoclonal antibodies ...Middle East

Story at a glance RSV is surging around the country after two seasons of low respiratory illnesses because of restrictions and public health measures to combat the coronavirus pandemic. There currently are no approved vaccines to prevent severe illness from RSV. Pfizer and Meissa have vaccine candidates in the works for pregnant and older people and for infants, respectively. RSV, which stands for respiratory syncytial virus, is surging in number of cases and hospitalizations in young patients across the country.  RSV can cause severe clinical problems in infants, particularly those under six months of age. It can also cause severe disease in older adults.

Hence then, the article about what to know about rsv vaccine candidates and monoclonal antibodies was published today ( Friday 18/11/2022 - 02:13 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( What to know about RSV vaccine candidates and monoclonal antibodies )

Also on site :

• Amazon’s ‘Breathable’ Athletic Skort Is a Tenniscore Staple That’s Perfect for Sports, Travel, and Errands
• Global Wellness Summit Announces Speakers and Topics--Including the Latest in Longevity Medicine, Women's Health, Wellness Travel and Neuroaesthetics
• Capri Pants Are on Trend for 2026 — Snag a Quick-Drying Cargo Pair That's ‘Perfect for Summer’ at Walmart